Company Filing History:
Years Active: 2014
Title: Junko Oki: Innovator in Pharmaceutical Composition and Screening Systems
Introduction
Junko Oki is a prominent inventor based in Ibaraki, Japan. She has made significant contributions to the field of pharmaceutical compositions and screening systems, particularly in relation to metabolic syndrome and blood glucose control. Her innovative work has led to the development of a unique method for screening substances that activate receptors associated with FGF21 activity.
Latest Patents
Junko Oki holds 1 patent for her invention titled "Method for screening a test substance for activating a receptor associated with FGF 21 activity." This patent describes a pharmaceutical composition that utilizes betaKlotho or substances that modulate betaKlotho activity as active ingredients. The invention aims to provide therapeutic solutions for metabolic syndrome, specifically targeting the control of blood glucose levels. Additionally, it includes a screening system designed to identify substances that enhance or suppress betaKlotho activity, utilizing a cell system that expresses FGF receptors and/or betaKlotho.
Career Highlights
Oki is affiliated with the National Institute of Advanced Industrial Science and Technology, where she continues to advance her research and innovations. Her work has garnered attention for its potential impact on treating metabolic disorders and improving health outcomes.
Collaborations
Junko Oki has collaborated with notable colleagues, including Masashi Suzuki and Toru Imamura, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Junko Oki's contributions to the field of pharmaceutical compositions and screening systems highlight her role as a leading inventor in Japan. Her innovative methods and collaborative efforts continue to pave the way for advancements in the treatment of metabolic syndrome.